Schonfeld Strategic Advisors LLC Pacira Bio Sciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 271,654 shares of PCRX stock, worth $6.53 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

271,654

Previous 507,736 46.5%

Holding current value

$6.53 Million

Previous $7.65 Million 33.08%

% of portfolio

0.03%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.3 - $20.33 $3.61 Million - $4.8 Million	-236,082 Reduced 46.5%	271,654 $5.12 Million
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $5.94 Million - $14.5 Million	507,736 New	507,736 $7.65 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $2.63 Million - $3.43 Million	100,053 New	100,053 $3.38 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $3.71 Million - $4.88 Million	102,823 New	102,823 $4.12 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $199,084 - $299,486	-5,213 Reduced 15.03%	29,472 $1.14 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $157,921 - $181,498	-3,082 Reduced 8.16%	34,685 $1.85 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $1.94 Million - $3.08 Million	37,767 New	37,767 $2.2 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $5.71 Million - $7.4 Million	-118,970 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$54.64 - $61.3 $2.81 Million - $3.15 Million	51,381 Added 76.02%	118,970 $6.66 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $2.49 Million - $2.94 Million	42,026 Added 164.4%	67,589 $4.1 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $1.52 Million - $2.01 Million	25,563 New	25,563 $1.79 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $661,157 - $868,006	-13,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $680,807 - $825,300	13,100 New	13,100 $788,000
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $337,783 - $575,438	-10,967 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $311,462 - $556,026	10,967 New	10,967 $368,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $2.98 Million - $3.85 Million	-82,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $449,315 - $566,874	12,600 Added 18.1%	82,200 $3.13 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $373,014 - $489,294	10,200 Added 17.17%	69,600 $3.03 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $1.44 Million - $1.67 Million	-39,611 Reduced 40.01%	59,400 $2.26 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $4.09 Million - $5.16 Million	99,011 New	99,011 $4.26 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $1.53 Million - $2.22 Million	-55,731 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $1.67 Million - $2.58 Million	55,731 New	55,731 $1.74 Million

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.1B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Pacira Bio Sciences, Inc. Transaction History